#biosimilar

Live, measured metrics for the hashtag #biosimilar from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #biosimilar

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$23.52/ year · 10-character #name
Claim #biosimilar — $23.52/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
24
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 24
0
Avg reactions / post
Mastodon · last 24
—
Reddit posts / month
Reddit search
—
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · mas.to (Mastodon public tags API) · fetched 2026-09-28 07:53 UTC
0
09-22
0
09-23
0
09-24
0
09-25
0
09-26
0
09-27
0
09-28

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · mas.to (Mastodon public search API) · fetched 2026-09-28 07:53 UTC

Live pulse

measured · mas.to (Mastodon tag timeline) · fetched 2026-09-28 07:53 UTC

Everything below is measured over the latest 24 public posts (spanning ~33320 hours).

Posting hours (UTC) — busiest: 10:00

00:0012:0023:00

Languages: English (19) · German (3) · Spanish (1) · French (1)

Avg boosts / post: 0.3

Top of the latest posts

  • https://www.europesays.com/es/760719/ El biosimilar JUNOD® refuerza el abordaje terapéutico frente a la osteoporosis #abordaje #acceso #atencion #biológicos #biosimilar #Biosimilares #calidad #contexto #continua #Denosumab #desarrollado #ef

    España@[email protected]♥ 0↻ 02026-09-12 00:50 UTCView post →
  • Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar September 3, 2026 |… #Euro

    Korea@[email protected]♥ 0↻ 02026-09-03 10:30 UTCView post →
  • Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar September 3, 2026 |… #Euro

    Japan@[email protected]♥ 0↻ 02026-09-03 09:20 UTCView post →

What “biosimilar” means

Wikipedia

A biosimilar is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

“Biosimilar” on Wikipedia (CC BY-SA) →

#biosimilar across platforms

every network with a public tag surface

Follow #biosimilar straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/biosimilar